Latest & greatest articles for obesity

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on obesity or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on obesity and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for obesity

81. Obesity, the new childhood disability? An umbrella review of systematic reviews on the association between adiposity and physical function

Obesity, the new childhood disability? An umbrella review of systematic reviews on the association between adiposity and physical function Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

82. Meta-analysis of the prevalence of sarcopenic obesity in Brazilian elderly

Meta-analysis of the prevalence of sarcopenic obesity in Brazilian elderly Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

83. Global prevalence of obesity, overweight and underweight in autism spectrum disorder and attention deficit hyperactivity disorder

Global prevalence of obesity, overweight and underweight in autism spectrum disorder and attention deficit hyperactivity disorder Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

84. Laparoscopic Roux-en-Y gastric bypass versus sleeve gastrectomy for type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis of randomized controlled trials

Laparoscopic Roux-en-Y gastric bypass versus sleeve gastrectomy for type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

85. The association of genetic markers with obesity: a systematic review

The association of genetic markers with obesity: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation

2019 PROSPERO

86. Systematic review on food environment interventions and policies in schools for the prevention of childhood obesity

Systematic review on food environment interventions and policies in schools for the prevention of childhood obesity Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

87. Psychological and clinical aspects of treatment with intragastric balloon for morbid obesity: a systematic review of the literature

Psychological and clinical aspects of treatment with intragastric balloon for morbid obesity: a systematic review of the literature Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

88. The effect of vitamin a supplementation compared to no vitamin a supplementation on obesity development in rats and mice

The effect of vitamin a supplementation compared to no vitamin a supplementation on obesity development in rats and mice Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

89. Effect of probiotics on biochemical and subjective indicators of hunger and satiety in overweight or obese patients: a systematic review and meta-analysis

Effect of probiotics on biochemical and subjective indicators of hunger and satiety in overweight or obese patients: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

90. Effects of vitamin D supplementation on fasting glucose, lipid profile, blood pressure, and abdominal obesity among patients with metabolic syndrome: a systematic review and meta-analysis of clinical trials

Effects of vitamin D supplementation on fasting glucose, lipid profile, blood pressure, and abdominal obesity among patients with metabolic syndrome: a systematic review and meta-analysis of clinical trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

91. Effectiveness of school-based interventions to prevent obesity among children aged 4 to 12 years in middle-income countries: a systematic review of randomised controlled trials

Effectiveness of school-based interventions to prevent obesity among children aged 4 to 12 years in middle-income countries: a systematic review of randomised controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

92. Dietary antioxidant capacity (TAC), general and central obesity indices, blood pressure, fasting blood sugar, biomarkers of insulin resistance and inflammation among adults

Dietary antioxidant capacity (TAC), general and central obesity indices, blood pressure, fasting blood sugar, biomarkers of insulin resistance and inflammation among adults Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

93. Interventions to prevent or treat childhood obesity in Maori and Pacific Islanders: a systematic review

Interventions to prevent or treat childhood obesity in Maori and Pacific Islanders: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

94. Probiotics for dyslipidemia, fatty liver, and obesity

Probiotics for dyslipidemia, fatty liver, and obesity Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2019 PROSPERO

95. Modifiable risk factors associated with obesity among children aged 2-18 years in Saudi Arabia: a systematic review and meta-analysis protocol

Modifiable risk factors associated with obesity among children aged 2-18 years in Saudi Arabia: a systematic review and meta-analysis protocol Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

96. Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial

Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial Maternal overweight and obesity are associated with well recognised pregnancy complications. Antenatal dietary and lifestyle interventions have a modest effect on gestational weight gain without affecting pregnancy outcomes. We aimed to assess the effects on maternal and infant outcomes of antenatal metformin given (...) in addition to dietary and lifestyle advice among overweight and obese pregnant women.GRoW was a multicentre, randomised, double-blind, placebo-controlled trial in which pregnant women at 10-20 weeks' gestation with a BMI of 25 kg/m2 or higher were recruited from three public maternity units in Adelaide, SA, Australia. Women were randomly assigned (1:1) via a computer-generated schedule to receive either metformin (to a maximum dose of 2000 mg per day) or matching placebo. Participants, their antenatal

2019 EvidenceUpdates

97. Efficacy of non-surgical periodontal therapy in the clinical outcomes of chronic periodontitis in obese patients compared to non-obese individuals

Efficacy of non-surgical periodontal therapy in the clinical outcomes of chronic periodontitis in obese patients compared to non-obese individuals Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

98. Interventions for weight loss in people with chronic kidney disease who are overweight or obese [Cochrane protocol]

Interventions for weight loss in people with chronic kidney disease who are overweight or obese [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

99. Fecal microbiota transplantation for metabolic syndrome and obesity: a systematic review and meta-analysis

Fecal microbiota transplantation for metabolic syndrome and obesity: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

100. Incidence of pathological findings in stomach of obesity individuals and cancer risk in follow-ups after bariatric surgery. A systematic review and meta-analysis

Incidence of pathological findings in stomach of obesity individuals and cancer risk in follow-ups after bariatric surgery. A systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO